Citi Sticks to Its Hold Rating for Avidity Biosciences (RNA)
at www.tipranks.com (Wed, 7-Jan 1:25 PM)
Wells Fargo Reaffirms Their Buy Rating on Avidity Biosciences (RNA)
at www.tipranks.com (Mon, 5-Jan 6:55 AM)
Novartis’s $12B Acquisition of Avidity Puts Spotlight on RNA Therapeutics and Late-Stage Neuromuscular Pipeline
Market Chameleon (Mon, 27-Oct 9:55 AM)
